Jennifer H. Foster, MD, MPH
- Cancer and Blood Disorders
Director, Solid Tumor Programs
Clinical Director, Neuroblastoma Program
Assistant Director, Developmental Therapeutics Program
Associate Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Phone:
832-822-4242
Fax:
832-825-1453
Languages: English
Office locations:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Jennifer H. Foster, MD, MPH
Dr. Jennifer Foster is a pediatric oncologist at Baylor College of Medicine/Texas Children’s Cancer and Hematology Center with clinical and research expertise in pediatric solid tumors and clinical pharmacology. She serves as Director of the Solid Tumor Programs, Clinical Director of the Neuroblastoma Program, and Assistant Director of the Developmental Therapeutics Program at Texas Children’s Cancer Center, one of the largest pediatric cancer center in the United States.
Her clinical and research interests are to bring novel therapies into early phase clinical trials for patients with neuroblastoma and other solid tumors, as well as to mitigate toxicities of therapy. As such, she is dual board certified in Pediatric Hematology-Oncology and Clinical Pharmacology. She has expertise in moving novel agents from the pre-clinical arena to the implementation of early phase clinical trials. She successfully completed the pre-clinical evaluation for the first-in-class NEDD8 activating enzyme inhibitor pevonedistat and partnered with Takeda to develop and conduct the Phase 1 clinical trial through the Children’s Oncology Group (COG).
As the site Principal Investigator for the National Cancer Institute’s Pediatric Early Phase Clinical Trials Network, she is responsible for the implementation and conduct of these trials at our institution, and is actively investigating novel agents through our Developmental Therapeutics pre-clinical program with the goal of incorporating them into future clinical trials.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor College of Medicine | Fellowship | Clinical Fellow, Pharmacology | 2015 |
| Baylor College of Medicine | Fellowship | Pediatric Hematology/Oncology | 2013 |
| University of Washington School of Medicine | Residency | Pediatrics | 2010 |
| University of Washington School of Medicine | Internship | Pediatrics | 2009 |
| University of Hawaii School of Medicine | Medical School | Doctor of Medicine | 2007 |
| San Diego State University | Masters | Masters in Public Health | 2003 |
| University of Notre Dame | Bachelors | Bachelor of Arts, Mandarin Chinese | 2001 |
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Medical Association (AMA) | Member |
| American Society of Pediatric Hematology/Oncology (ASPHO) | Member |
Board Certification
American Board of Pediatrics - Pediatrics
American Board of Pediatrics - Pediatric Hematology-Oncology
Honors and awards
- 2022
-
Dr. Peter Adamson Young Investigator Award, Children's Oncology Group (COG)
- 2020
-
Research Mentor Award, Texas Children's Hospital
- 2019
-
Faculty Award for Excellence in Patient Care, Baylor College of Medicine
- 2017
-
Awardee Rising Star in Translational Cancer Research, Society for Translational Oncology
- 2013
-
Alex’s Lemonade Stand Foundation, Research Scholar
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
